| 标题 |
Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial |
| 网址 | |
| DOI |
10.1016/S1470-2045(23)00276-0
doi
|
| 其它 |
期刊:Lancet Oncology 作者:Laurence Albigès; Howard Gurney; Vagif Atduev; Cristina Suárez; Miguel Ángel Climent; et al 出版日期:2023-07-11 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)